000			01141nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aPreventing the Adverse Effects of SARS-CoV-2 Infection and COVID-19 through Diet, Supplements and Lifestyle
546			_aEnglish[eng]
650			_avitamin D||COVID-19||SARS-CoV-2||severity||mortality||United Arab Emirates||clinical trial||saudi||vitamin D insufficiency||glycyrrhizin||mineralocorticoid receptor||toll like receptor 4||angiotensin converting enzyme||aldosterone||coronavirus||exercise||emotional eating||pandemic||quarantine||questionnaire||sedentariness||New York||hesperidin||TMPRSS2||ACE2||D614G||501Y.v2||vitamin D deficiency||25(OH)D||obesity||CACFP||early care and education||food program||food supplements||immunity||zinc||lifestyle||Poland||clinical symptoms||vitamin D status||zinc status||sunlight exposure||prevention||food hygiene||bioactive compounds||diet||n/a||diabetes mellitus||oxidative stress||kidney damage||antioxidant
700			_aGrant, William B.||Lordan, Ronan
856			_uhttps://mdpi.com/books/pdfview/book/5400
942			_cEB
999			_c22250 _d22250